In Brief Candel Therapeutics partners with UPenn to study viral immunotherapy and CAR T-cell therapy October 28, 2022Vol.48 No.39
In Brief Max Foundation, ABC Global Alliance, American Society of Clinical Pathology, Cepheid, Novartis AG collaborate to improve advanced breast cancer outcomes in low-resource countries October 28, 2022Vol.48 No.39
Clinical Roundup In phase II study, Talzenna shrank tumors in breast cancer patients with PALB2 mutations October 28, 2022Vol.48 No.39
Clinical Roundup New analysis finds sequencing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer October 28, 2022Vol.48 No.39
Clinical Roundup Metastasis-directed radiation therapy plus hormone therapy improves PFS for men with advanced prostate cancer October 28, 2022Vol.48 No.39
Clinical Roundup VCU Massey scientists pinpoint druggable target in TNBC October 28, 2022Vol.48 No.39
Clinical Roundup FLASH radiation therapy shows promise in first-in-human trial October 28, 2022Vol.48 No.39
Clinical Roundup Analysis of radiotherapy and locoregional recurrence in RxPONDER patients October 28, 2022Vol.48 No.39
Drugs & Targets FDA approves Imjudo in combination with Imfinzi for unresectable hepatocellular carcinoma October 28, 2022Vol.48 No.39
